Skip to main content
Legal CJC-1295

An instrument-cluster reading of the CJC-1295 record — what the research establishes, and exactly where its regulatory and anti-doping status actually stands.

WHAT THIS SITE CAN AND CANNOT DO

Legal CJC-1295 is an information site, not a clinic.

CJC-1295 is unapproved; this page explains the site's limits and the few facts the studies can support.

This information site isn't a clinic

Legal CJC-1295 explains medical studies and public rulings about the drug. It doesn't see patients, write prescriptions, sell products, or give medical advice.

The site gives a source for each main fact. It also tells you when no study has answered a question.

CJC-1295 is often described poorly online. Its FDA status gets blurred, and DAC, the version linked to a blood protein, gets confused with the brief version without that link.

Human studies, FDA papers, and CJC-1295 sport rules answer different questions. Keeping them apart helps you see what each source can truly show.

No doctor or nurse works through this site. Nothing here can judge your health or tell you to use, seek, or avoid the drug.

Small studies answer only blood-test questions

The human studies say who took CJC-1295 and which blood levels changed. They also leave many questions unanswered.

For example, small studies show that long-form DAC raised growth hormone and IGF-1, a blood test tied to growth, for days. They don't show long-term safety or a clear health benefit for healthy adults.

A number beside a fact leads to the named item on the full source list. You can open that study or public record and see what it found.

No published source shows that the drug helps healthy adults over the long run. Seller claims cannot fill that gap.